C2i and Hitachi Launch First Automated Organoid Culture System in Hong Kong

by Medical

Hong Kong based Centre for Immunology & Infection Limited (C2i), its spin-off C2iTech, and Japanese multinational conglomerate Hitachi have announced a strategic collaboration to develop 3D printed airway organoids for clinical applications.  C2i also unveiled Hong Kong’s first automated organoid culture system, located at the Hong Kong Science Park (HKSTP). These joint efforts aim to enhance the efficiency, scalability, and standardization of organoid production, driving advancements in personalized medicine and regenerative therapies.

Dimension Ortho Partners with Rothman Orthopaedics to Advance Personalized Fracture Care

by Medical

Dimension Ortho, a provider of 3D printed orthotics, has entered into a partnership with Rothman Orthopaedics, a major U.S.-based orthopedic practice recognized for its work in musculoskeletal care. This collaboration will enable Rothman to implement Dimension Ortho’s platform for customized bracing and fracture care across its clinical network, with the goal of elevating patient care standards.

Ricoh launches Ricoh 3D for Healthcare, LLC to accelerate patient-specific device adoption

by Medical

Ricoh USA, the North American arm of the Japanese digital services multinational, has announced the formation of Ricoh 3D for Healthcare, LLC, a new legal entity dedicated to delivering FDA-cleared, patient-specific 3D printed medical devices at hospitals across the United States. The company, unveiled on June 17, 2025, will enhance Ricoh’s ability to meet growing clinical demand for personalized care, streamline regulatory compliance, and support point-of-care manufacturing.

3D Printed Motor Neuron Organoids by Uppsala Researchers Could Accelerate ALS Drug Development

by Medical

Researchers at Uppsala University in Sweden have developed 3D printed models from patient-derived cells to simulate motor neurons in the lab. These structures, known as motor neuron organoids, are expected to support research into neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and help explore treatment strategies without the need for invasive procedures.

Stanford Develops 3D Printing Algorithm to Advance Vascular Design for Organ Bioprinting

by Medical

Stanford researchers have taken a major step toward addressing one of the biggest hurdles in organ bioprinting: building realistic vascular networks capable of sustaining lab-grown tissue. Their new platform, published June 12 in Science, accelerates the design of these blood vessel systems and translates them into 3D printable models—bringing the promise of personalized, functional organs closer to reality.